Zhang Rui, Lin Peng, Yang Xia, He Rong-Quan, Wu Hua-Yu, Dang Yi-Wu, Gu Yong-Yao, Peng Zhi-Gang, Feng Zhen-Bo, Chen Gang
Department of Pathology, First Affiliated Hospital of Guangxi Medical University 6 Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Department of Ultrasonography, First Affiliated Hospital of Guangxi Medical University 6 Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Am J Transl Res. 2018 Aug 15;10(8):2636-2647. eCollection 2018.
Growing evidence has revealed that the initiation of various malignancies is closely associated with alternative splicing (AS) events in certain key oncogenes. However, in diffuse large B-cell lymphoma (DLBCL), there is still a great deal to learn about AS variants. In this study, 33,724 AS variant profiles were obtained from 16,278 genes in 48 DLBCL cases. A total of 10 AS variants were identified as overall survival (OS)- related events via multivariate Cox regression analysis. Notably, alternative donor (AD) sites in AS events in the low-risk group showed a significantly better outcome in DLBCL patients than in the high-risk group (P=0.0002). The area under the curve (AUC) of the receiver-operator characteristic curve (ROC) for ADs in DLBCL was 0.746. Furthermore, 66 related splicing factors were obtained to investigate their potential correlations with AS events. Factors SF1, HNRNPC, HNRNPD, and HNRNPH3 were significantly involved in different OS-related AS variants. Collectively, we constructed valuable prognostic predictors for DLBCL patients and mapped novel splicing networks for further investigation of the underlying mechanisms related to AS variants in DLBCLs.
越来越多的证据表明,各种恶性肿瘤的发生与某些关键癌基因中的可变剪接(AS)事件密切相关。然而,在弥漫性大B细胞淋巴瘤(DLBCL)中,关于AS变体仍有很多需要了解的地方。在本研究中,从48例DLBCL病例的16278个基因中获得了33724个AS变体图谱。通过多变量Cox回归分析,共鉴定出10个与总生存期(OS)相关的AS变体。值得注意的是,低风险组AS事件中的可变供体(AD)位点在DLBCL患者中的预后明显优于高风险组(P = 0.0002)。DLBCL中AD的受试者工作特征曲线(ROC)的曲线下面积(AUC)为0.746。此外,获得了66个相关剪接因子,以研究它们与AS事件的潜在相关性。因子SF1、HNRNPC、HNRNPD和HNRNPH3显著参与了不同的与OS相关的AS变体。总的来说,我们为DLBCL患者构建了有价值的预后预测指标,并绘制了新的剪接网络,以进一步研究与DLBCL中AS变体相关的潜在机制。